Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Delenex Therapeutics

Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.

Acquired by Cell Medica on July 12, 2016

Website: https://www.delenex.com

Founded: January 01, 2009

Social:

Add Competitor

Startup	Industry	Description
Healables	Pharmaceuticals & Biotechnology	Biotech & Digital Health - Wearables that Heal - Healables develops innovative drug-free pain-relie ...
PrognoCIS	Healthcare Equipment & Services	Telemedicine EHR software - PrognoCIS EHR Software is a product rich in featur ...
SciNote ELN	Software, Internet & Computer Services	Top-rated Electronic Lab Notebook - SciNote is a top-rated Electronic Lab Notebook for ...

View more competitors»

Date	Round	Amount	Investors
Jan 01, 2016	Series A	Undisclosed amount	SV Health Investors
Nov 06, 2013	Series A	$ 8,000,000	BioMedPartners HBM BioVentures Novo A/S SV Health Investors VI Partners
May 01, 2011	Series A	$ 19,300,000	SV Health Investors BioMedPartners HBM BioVentures VI Partners

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Eric de la Fortelle	CEO	Unknown to Present